IBL HealthCare Ltd
Shariah compliantAlphaGen's view
Members only- Alpha scoreHow this quarter's business compares, scored 0–100
- Fair valueWhat the stock may be worth, against today's price
- Trend signalWhether the price trend is up, down or stopping
- Sector rankWhere it stands among its sector peers
Latest results
Quarter: Apr–Jun 2026In the Apr–Jun 2026 quarter, IBLHL's sales rose 11% to Rs 1.3bn, from Rs 1.2bn, and profit after tax fell 28% to Rs 52.4mn, from Rs 73.0mn (compared with Apr–Jun 2025).
Earnings per share were Rs 0.44, against Rs 0.59 a year earlier.
At Rs 40.40, IBLHL trades at 19.1 times earnings.
- P/E ratio
- 19.1
- Dividend yield
- 0.0%
- Dividend payout
- 0%
- of earnings
- Return on equity
- 9%
- Net margin
- 5.0%
- trailing twelve months
- Debt to equity
- 0.01
IBLHL quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Apr–Jun 2026 | Rs 1.3bn | Rs 52.4mn | 4.0% | Rs 0.44 | — |
| Jan–Mar 2026 | Rs 1.2bn | Rs 62.0mn | 5.1% | Rs 0.63 | — |
| Oct–Dec 2025 | Rs 971.0mn | Rs 36.0mn | 3.7% | Rs 0.36 | — |
| Jul–Sep 2025 | Rs 1.1bn | Rs 70.0mn | 6.2% | Rs 0.81 | — |
| Apr–Jun 2025 | Rs 1.2bn | Rs 73.0mn | 6.2% | Rs 0.59 | — |
| Jan–Mar 2025 | Rs 948.0mn | Rs 35.0mn | 3.7% | Rs 0.41 | — |
| Oct–Dec 2024 | Rs 1.1bn | Rs 40.0mn | 3.6% | Rs 0.41 | — |
| Jul–Sep 2024 | Rs 1.1bn | Rs 60.0mn | 5.6% | Rs 0.70 | — |
IBLHL annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Jun 2026 | Rs 4.6bn | Rs 220.4mn | Rs 2.24 | — |
| Year to Jun 2025 | Rs 4.3bn | Rs 208.0mn | Rs 2.11 | — |
| Year to Jun 2024 | Rs 3.6bn | Rs 8.0mn | Rs 0.09 | — |
| Year to Jun 2023 | Rs 4.0bn | Rs 309.0mn | Rs 3.61 | — |
| Year to Jun 2022 | Rs 3.7bn | Rs 303.0mn | Rs 3.53 | Rs 0.76 |
Balance sheet and price
Balance sheet as of Jun 2026- Total assets
- Rs 4.0bn
- Shareholders' equity
- Rs 2.5bn
- Cash & bank
- Rs 727.2mn
- Total debt
- Rs 26.6mn
- Current ratio
- 2.30
- 3-month high
- Rs 58.13
- 3-month low
- Rs 40.40
- 1-month change
- -12.3%
- 3-month change
- -30.5%
Read more about IBLHL
Other pharmaceuticals companies
- ABOTAbbot Laboratories (Pakistan) LtdRs 927.73P/E 11.1
- AGPAGP LtdRs 157.87P/E 12.7
- BFBIOBF Biosciences LtdRs 127.51P/E 20.0
- CPHLCiti Pharma LtdRs 71.86P/E 15.7
- FEROZFerozsons Laboratories LtdRs 325.07P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 316.42P/E 10.4
- HALEONHaleon Pakistan LtdRs 680.74P/E 12.7
- HINOONHighnoon Laboratories LtdRs 948.13P/E 12.1
- HPLHoehcst Pakistan LtdRs 3905.85P/E 10.4
- LIVENLiven Pharma LimitedRs 31.14
- MACTERMacter International LtdRs 259.64P/E 15.3
- OTSUOtsuka Pakistan LtdRs 366.30P/E 14.4
IBLHL: common questions
What is IBLHL's share price?
IBL HealthCare Ltd (IBLHL) last closed at Rs 40.40 on the Pakistan Stock Exchange.
Does IBLHL pay a dividend?
IBL HealthCare Ltd reported no dividend for the year to Jun 2026.
What were IBLHL's latest results?
In the Apr–Jun 2026 quarter, IBLHL's sales rose 11% to Rs 1.3bn, from Rs 1.2bn, and profit after tax fell 28% to Rs 52.4mn, from Rs 73.0mn (compared with Apr–Jun 2025).
What is IBLHL's P/E ratio?
At Rs 40.40, IBLHL trades at 19.1 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.